Extract from M&A Insights

The below story was originally featured in our daily M&A Insights Newsletter. Selected stories, including this one, are posted to our website with a few weeks of delay.
Abacus Medicine to IPO at DKK 1.2-1.3bn valuation in May
May 23, 2019

Abacus Medicine, a Danish-based parallel importer and distributor of prescription drugs across Europe. Abacus expects to raise EUR 79.2m in the IPO. Abacus Medicine reported a LTM turnover of EUR 339.6m and LTM EBITDA of EUR 13.3m by March 2019, which corresponds to an EV/EBITDA multiple of 12-13.3x. Abacus will be listed on Frankfurt Stock Exchange.

ⓘ This story was originally featured in our daily M&A Insights newsletter.
Our insights have been covered by: